N
GMED icon

Natixis’s Globus Medical GMED Stock Holding History

Natixis’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-16,192
Closed -$1.41M – 1196
2025
Q4 		$1.41M Buy
+16,192
New +$1.23M 0.01% 672
2025
Q3 		– Sell
-40
Closed -$2.36K – 1126
2025
Q2 		$2.36K Buy
+40
New +$2.58K ﹤0.01% 981
2024
Q2 		– Sell
-34,996
Closed -$1.88M – 1059
2024
Q1 		$1.88M Sell
34,996
-16,704
-32% -$898K 0.01% 450
2023
Q4 		$2.76M Buy
+51,700
New +$2.52M 0.02% 364
2022
Q4 		– Sell
-106,020
Closed -$6.32M – 1198
2022
Q3 		$6.32M Sell
106,020
-97,300
-48% -$5.86M 0.03% 360
2022
Q2 		$11.4M Buy
+203,320
New +$13.4M 0.04% 271
2021
Q4 		– Sell
-78,400
Closed -$6.01M – 1283
2021
Q3 		$6.01M Buy
78,400
+50,700
+183% +$4.07M 0.02% 498
2021
Q2 		$2.15M Buy
+27,700
New +$1.97M 0.01% 513
2020
Q2 		– Sell
-64,239
Closed -$2.73M – 789
2020
Q1 		$2.73M Sell
64,239
-16,543
-20% -$817K 0.02% 344
2019
Q4 		$4.75M Buy
80,782
+47,936
+146% +$2.6M 0.03% 414
2019
Q3 		$1.68M Buy
+32,846
New +$1.56M 0.01% 515
2019
Q2 		– Sell
-72,449
Closed -$3.52M – 814
2019
Q1 		$3.52M Sell
72,449
-3,861
-5% -$175K 0.02% 430
2018
Q4 		$3.3M Buy
76,310
+9,108
+14% +$454K 0.03% 379
2018
Q3 		$3.81M Buy
67,202
+1,791
+3% +$94.2K 0.02% 416
2018
Q2 		$3.3M Buy
65,411
+1,970
+3% +$103K 0.02% 438
2018
Q1 		$3.16M Buy
63,441
+28,165
+80% +$1.32M 0.02% 438
2017
Q4 		$1.45M Buy
+35,276
New +$1.23M 0.01% 448
2017
Q3 		– Sell
-22,396
Closed -$742K – 1297
2017
Q2 		$742K Buy
22,396
+2,673
+14% +$84K 0.01% 454
2017
Q1 		$584K Buy
+19,723
New +$538K 0.01% 487

Other funds holding GMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Natixis's GMED Position: Q1 2026 in Review

Natixis sold out of Globus Medical (GMED) in Q1 2026, closing a stake of 16,192 shares — an estimated $1.41M sold.

Natixis first reported a position in GMED in Q1 2017 and held it in 19 quarters. The position peaked at $11.4M in Q2 2022. 602 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

  • Natixis reported no remaining Globus Medical position as of Q1 2026 after selling out during the quarter.
  • Natixis sold 16,192 Globus Medical shares in Q1 2026, an estimated $1.41M.
  • Natixis first reported a position in Globus Medical in Q1 2017 and held it in 19 quarters.
  • Natixis's Globus Medical position peaked at $11.4M in Q2 2022.
  • 602 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on Natixis's 13F filing for Q1 2026, filed 14 May 2026.